THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) announced today that it plans to publicly offer 2,500,000 shares of its common stock pursuant to an effective registration statement previously filed with the Securities and Exchange Commission. In connection with this offering, Repros plans to grant to the underwriters a 30-day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any. All of the shares are being offered by Repros. CIBC World Markets Corp. is acting as sole book-running manager in this offering. Punk Ziegel & Company is acting as co-lead manager. ThinkEquity Partners LLC is acting as co-manager.
